BMO Capital Upgrades Merck & Co to Outperform, Announces $132 Price Target
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Evan David Seigerman has upgraded Merck & Co (NYSE:MRK) from Market Perform to Outperform and set a new price target of $132.
October 27, 2023 | 10:26 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merck & Co has been upgraded to Outperform by BMO Capital, with a new price target of $132.
The upgrade from BMO Capital is a positive signal for Merck & Co. The new price target of $132 suggests a significant upside potential from the current price. This could lead to increased investor interest and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100